Abstract:Background: The cAMP response element-binding protein (CREB) and CREB-regulated transcription coactivators (CRTCs) cooperate in the transcriptional activation of microphthalmia-associated transcription factor subtype M (MITF-M) that is a master regulator in the biogenesis, pigmentation and transfer of melanosomes at epidermal melanocytes. Here, we propose the targeting of phosphorylation circuits on CREB and CRTCs in the expression of MITF-M as the rationale to prevent skin hyperpigmentation by elucidating the inhibitory activity and mechanism of yakuchinone A (Yaku A) on facultative melanogenesis. Methods: We employed human epidermal melanocyte cell, mouse skin, and mouse melanoma cell, and applied Western blotting, reverse transcription-polymerase chain reaction, immunoprecipitation and confocal microscopy to conduct this study. Results: This study suggested that α-melanocyte stimulating hormone (α-MSH)-induced melanogenic programs could switch on the axis of protein kinase A-salt inducible kinases (PKA-SIKs) rather than that of PKA-AMP activated protein kinase (PKA-AMPK) during the dephosphorylation of CRTCs in the expression of MITF-M. SIK inhibitors rather than AMPK inhibitors stimulated melanin production in melanocyte cultures in the absence of extracellular melanogenic stimuli, wherein SIK inhibitors increased the dephosphorylation of CRTCs but bypassed the phosphorylation of CREB for the expression of MITF-M. Treatment with Yaku A prevented ultraviolet B (UV-B)-irradiated skin hyperpigmentation in mice and inhibited melanin production in α-MSH- or SIK inhibitor-activated melanocyte cultures. Mechanistically, Yaku A suppressed the expression of MITF-M via dually targeting the i) cAMP-dependent dissociation of PKA holoenzyme at the upstream from PKA-catalyzed phosphorylation of CREB coupled with PKA-SIKs axis-mediated dephosphorylation of CRTCs in α-MSH-induced melanogenic programs, and ii) nuclear import of CRTCs after SIK inhibitor-induced dephosphorylation of CRTCs. Conclusions: Taken together, the targeting phosphorylation circuits on CREB and CRTCs in the expression of MITF-M could be a suitable strategy to prevent pigmentary disorders in the skin.

MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes

C-KIT Signaling Depends on Microphthalmia-Associated Transcription Factor for Effects on Cell Proliferation

Lipocalin-type Prostaglandin D Synthase As a Melanocyte Marker Regulated by MITF.

MITF: A Stream Flowing for Pigment Cells

[Regulation of melanogenesis: the role of cAMP and MITF]

The Role of MITF Phosphorylation Sites During Coat Color and Eye Development in Mice Analyzed by Bacterial Artificial Chromosome Transgene Rescue

MITF: master regulator of melanocyte development and melanoma oncogene

Allele-specific genetic interactions between Mitf and Kit affect melanocyte development.

Stem Cell Factor-Inducible MITF-M Expression in Therapeutics for Acquired Skin Hyperpigmentation

Microphthalmia-Associated Transcription Factor (MITF): Multiplicity in Structure, Function, and Regulation

Genetic Control of MAP3K1 in Eye Development and Sex Differentiation

The MITF regulatory network in melanoma

MITF reprograms the extracellular matrix and focal adhesion in melanoma

The changes of microRNA expression profiles and tyrosinase related proteins in MITF knocked down melanocytes

Microphthalmia-Associated Transcription Factor/T-Box Factor-2 Axis Acts Through Cyclin D1 to Regulate Melanocyte Proliferation

MITF in melanoma: mechanisms behind its expression and activity

MNK1/2 Inhibition Limits Oncogenicity and Metastasis of KIT-mutant Melanoma

Insights into the regulation of MAP3K1 in hair follicle stem cells by transcriptome analysis

Targeting phosphorylation circuits on CREB and CRTCs as the strategy to prevent acquired skin hyperpigmentation

Melanocortin 1 receptor mediates melanin production by interacting with the BBSome in primary cilia

The MITF/mir-579-3p regulatory axis dictates BRAF-mutated melanoma cell fate in response to MAPK inhibitors